Hyperammonemia is a key factor in the pathogenesis of hepatic encephalopathy (HE) as well as other metabolic encephalopathies, such as those associated with inherited disorders of urea cycle enzymes and in Reye's syndrome. Acute HE results in increased brain ammonia (up to 5 mM), astrocytic swelling, and altered glutamatergic function. In the present study, using fluorescence imaging techniques, acute exposure (10 min) of ammonia (NH 4 ؉ /NH 3 ) to cultured astrocytes resulted in a concentration-dependent, transient increase in [Ca 2؉ ] i . This calcium transient was due to release from intracellular calcium stores, since the response was thapsigargin-sensitive and was still observed in calcium-free buffer. Using an enzyme-linked fluorescence assay, glutamate release was measured indirectly via the production of NADH (a naturally fluorescent product when excited with UV light). Hyperammonemia consequently leads to increased concentrations of ammonia, up to 5 mM, in the brain. This high level of brain ammonia is a key factor in the pathogenesis of central nervous system dysfunction in acute and chronic liver failure. The nature and severity of the central nervous system disorder mainly depend upon the degree and acuteness of the onset of hyperammonemia (1). Acute liver failure (ALF) 1 resulting from viral infections or toxic liver injury is a life-threatening condition where hepatic encephalopathy (HE) develops rapidly and mortality rates are high due to brain stem herniation caused by increased intracranial pressure, a fatal consequence of cytotoxic brain edema. Excess ammonia is toxic to the brain resulting in deleterious effects, by both direct and indirect mechanisms, on cerebral metabolism and neurotransmission.Over the past 10 years, there has been an increasing body of evidence demonstrating that ammonia toxicity is involved in alterations of glutamatergic synaptic regulation which is implicated in the pathophysiology of HE in ALF. Several reports have consistently described increased extracellular concentrations of brain glutamate in different models of experimental ALF (2-5); however, neither the cell type nor the underlying release mechanisms have been identified. One possible explanation for the increased extracellular glutamate may be ammonia's inhibitory effects on the glutamate transporter system in astrocytes. It has been shown that ammonia inhibits glutamate uptake into astrocytes in vitro (6) and decreases protein and gene expression of the glutamate transporter GLT-1 (EAAT-2) in the frontal cortex of rats with ALF (7). The role of ammonia in the glutamatergic dysfunction demonstrated in HE is supported with a positive correlation between extracellular brain concentrations of glutamate and arterial ammonia concentrations in ALF in rats (4). In addition, using mild hypothermia as a treatment in rats with ALF, extracellular brain glutamate concentrations were normalized concomitantly with a lowering of brain ammonia (8).Glutamate has been demonstrated to be an important signaling molecule for neuro...